Immunocore (IMCR) News Today $28.33 -0.09 (-0.32%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Immunocore (NASDAQ:IMCR) Hits New 1-Year Low - Time to Sell?Immunocore (NASDAQ:IMCR) Hits New 52-Week Low - Time to Sell?December 19 at 6:17 AM | marketbeat.comImmunocore Holdings plc (NASDAQ:IMCR) Short Interest Down 5.4% in NovemberDecember 18 at 1:55 AM | americanbankingnews.comImmunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancersDecember 17, 2024 | markets.businessinsider.comImmunocore Holdings plc (NASDAQ:IMCR) Sees Significant Decline in Short InterestImmunocore Holdings plc (NASDAQ:IMCR - Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 30th, there was short interest totalling 7,190,000 shares, a decrease of 5.4% from the November 15th total of 7,600,000 shares. Currently, 14.8% of the shares of the company are sold short. Based on an average daily trading volume, of 277,800 shares, the short-interest ratio is currently 25.9 days.December 17, 2024 | marketbeat.comImmunocore (NASDAQ:IMCR) Earns "Equal Weight" Rating from Morgan StanleyDecember 15, 2024 | americanbankingnews.comImmunocore Hldgs (NASDAQ:IMCR) Stock, Short Interest ReportDecember 14, 2024 | benzinga.comMorgan Stanley Downgrades Immunocore Holdings plc - Depositary Receipt () (IMCR)December 14, 2024 | msn.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 91,033 Shares of Immunocore Holdings plc (NASDAQ:IMCR)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 7,437.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC).December 14, 2024 | marketbeat.comImmunocore (NASDAQ:IMCR) Sets New 12-Month Low - What's Next?Immunocore (NASDAQ:IMCR) Hits New 1-Year Low - Time to Sell?December 13, 2024 | marketbeat.comImmunocore's (IMCR) "Equal Weight" Rating Reiterated at Morgan StanleyMorgan Stanley reaffirmed an "equal weight" rating and issued a $35.00 target price (down previously from $74.00) on shares of Immunocore in a report on Friday.December 13, 2024 | marketbeat.comImmunocore, EORTC announce enrollment of first patient in Phase 3 ATOM trialDecember 11, 2024 | markets.businessinsider.comEORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanomaDecember 11, 2024 | finance.yahoo.comImmunocore Holdings plc (NASDAQ:IMCR) Receives Average Rating of "Moderate Buy" from AnalystsShares of Immunocore Holdings plc (NASDAQ:IMCR - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the thirteen ratings firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, three have issued aDecember 11, 2024 | marketbeat.comImmunocore Is Adequately Valued, But Its Prospects Are UncertainDecember 10, 2024 | seekingalpha.comVerition Fund Management LLC Acquires New Position in Immunocore Holdings plc (NASDAQ:IMCR)Verition Fund Management LLC bought a new position in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 23,755 shares of the company's stock, valued at approximately $739,000December 10, 2024 | marketbeat.comWellington Management Group LLP Raises Position in Immunocore Holdings plc (NASDAQ:IMCR)Wellington Management Group LLP increased its holdings in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 10.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,048,833 shares of the company's stDecember 9, 2024 | marketbeat.comTwo Sigma Advisers LP Acquires 300,200 Shares of Immunocore Holdings plc (NASDAQ:IMCR)Two Sigma Advisers LP lifted its stake in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 65.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 757,700 shares of the company's stock after buying an additioDecember 8, 2024 | marketbeat.comFmr LLC Purchases 23,436 Shares of Immunocore Holdings plc (NASDAQ:IMCR)Fmr LLC raised its holdings in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 0.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,836,040 shares of the company's stock after buying an additionalDecember 4, 2024 | marketbeat.comImmunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanomaDecember 3, 2024 | globenewswire.comImmunocore Holdings plc (NASDAQ:IMCR) Shares Acquired by Bellevue Group AGBellevue Group AG increased its stake in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 4.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,205,464 shares of the company's stock after purchasing anDecember 1, 2024 | marketbeat.comMassachusetts Financial Services Co. MA Buys 107,656 Shares of Immunocore Holdings plc (NASDAQ:IMCR)Massachusetts Financial Services Co. MA increased its position in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 27.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 498,221 shares of the company's stock after acquirNovember 26, 2024 | marketbeat.comImmunocore Holdings plc (NASDAQ:IMCR) Shares Bought by BNP PARIBAS ASSET MANAGEMENT Holding S.A.BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its position in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 7.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 427,152 shares of the company's stock after purchasing an additional 29,689November 24, 2024 | marketbeat.comPrimecap Management Co. CA Boosts Stake in Immunocore Holdings plc (NASDAQ:IMCR)Primecap Management Co. CA grew its position in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 26.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,472,020 shares of the company's stock after acquirinNovember 22, 2024 | marketbeat.comImmunocore Holdings plc (IMCR): This Small-Cap Stock Is Ready To ExplodeNovember 19, 2024 | insidermonkey.comIs Immunocore Holdings plc (IMCR) the Best Immunotherapy Stock to Buy Now?November 19, 2024 | msn.comImmunocore Holdings plc (NASDAQ:IMCR) Given Consensus Recommendation of "Moderate Buy" by AnalystsImmunocore Holdings plc (NASDAQ:IMCR - Get Free Report) has earned an average recommendation of "Moderate Buy" from the thirteen research firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, three have given a hold rating and nine hNovember 16, 2024 | marketbeat.comCrossmark Global Holdings Inc. Invests $866,000 in Immunocore Holdings plc (NASDAQ:IMCR)Crossmark Global Holdings Inc. bought a new position in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 27,803 shares of the company's stock, valueNovember 15, 2024 | marketbeat.comPrincipal Financial Group Inc. Grows Stock Position in Immunocore Holdings plc (NASDAQ:IMCR)Principal Financial Group Inc. grew its position in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 25.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 546,318 shares of the company's stock after buyiNovember 15, 2024 | marketbeat.comImmunocore Holdings (IMCR) Gets a Buy from J.P. MorganNovember 12, 2024 | markets.businessinsider.comMizuho Downgrades Immunocore Holdings plc - Depositary Receipt () (IMCR)November 12, 2024 | msn.comImmunocore downgraded to Neutral from Outperform at MizuhoNovember 11, 2024 | markets.businessinsider.comMizuho Downgrades Immunocore (NASDAQ:IMCR) to NeutralMizuho lowered Immunocore from an "outperform" rating to a "neutral" rating and reduced their price target for the stock from $72.00 to $38.00 in a report on Monday.November 11, 2024 | marketbeat.comNavigating 8 Analyst Ratings For Immunocore HldgsNovember 11, 2024 | benzinga.com3 Fast-Growing Stocks Analysts See Doubling in Price (IMCR)Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.November 11, 2024 | marketbeat.comAnalysts Set Expectations for Immunocore FY2024 EarningsImmunocore Holdings plc (NASDAQ:IMCR - Free Report) - Investment analysts at HC Wainwright boosted their FY2024 earnings estimates for Immunocore in a research note issued on Thursday, November 7th. HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per share ofNovember 11, 2024 | marketbeat.comFiera Capital Corp Decreases Position in Immunocore Holdings plc (NASDAQ:IMCR)Fiera Capital Corp lowered its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 3.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 845,732 shares of the company's stock after selling 29,861 sharNovember 9, 2024 | marketbeat.comImmunocore Holdings: Strategic Advancements and Financial Stability Support Buy RatingNovember 8, 2024 | markets.businessinsider.comImmunocore to present at upcoming investor conferencesNovember 8, 2024 | globenewswire.comLeerink Partnrs Raises Earnings Estimates for ImmunocoreImmunocore Holdings plc (NASDAQ:IMCR - Free Report) - Equities research analysts at Leerink Partnrs boosted their FY2024 EPS estimates for Immunocore in a research note issued on Wednesday, November 6th. Leerink Partnrs analyst J. Chang now expects that the company will post earnings per share ofNovember 8, 2024 | marketbeat.comImmunocore Hldgs (NASDAQ:IMCR) Stock, Option ChainNovember 7, 2024 | benzinga.comImmunocore Holdings: Strong Buy Rating Backed by Successful KIMMTRAK Launch and Promising Clinical PipelineNovember 7, 2024 | markets.businessinsider.comBarclays Keeps Their Buy Rating on Immunocore Holdings (IMCR)November 7, 2024 | markets.businessinsider.comNeedham & Company LLC Cuts Immunocore (NASDAQ:IMCR) Price Target to $71.00Needham & Company LLC cut their price objective on shares of Immunocore from $78.00 to $71.00 and set a "buy" rating for the company in a report on Thursday.November 7, 2024 | marketbeat.comImmunocore reports third quarter financial results and provides a business updateNovember 6, 2024 | globenewswire.comImmunocore (NASDAQ:IMCR) Stock Price Up 7.4% - Should You Buy?Immunocore (NASDAQ:IMCR) Stock Price Up 7.4% - Here's What HappenedOctober 28, 2024 | marketbeat.comUBS Initiates Coverage of Immunocore Holdings plc - Depositary Receipt () (IMCR) with Sell RecommendationOctober 25, 2024 | msn.comImmunocore initiated with a Sell at UBSOctober 25, 2024 | markets.businessinsider.comUBS launches SMID cap biotechs with cancer, autoimmunity in focusOctober 24, 2024 | seekingalpha.comImmunocore's (IMCR) Buy Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $100.00 target price on shares of Immunocore in a research report on Thursday.October 24, 2024 | marketbeat.comUBS Group Initiates Coverage on Immunocore (NASDAQ:IMCR)UBS Group began coverage on shares of Immunocore in a research note on Thursday. They set a "sell" rating and a $24.00 price objective on the stock.October 24, 2024 | marketbeat.com Get Immunocore News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Your chance to get on the next “60-Second Trade” (Ad)Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday! Just head over here! IMCR Media Mentions By Week IMCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMCR News Sentiment▼0.610.60▲Average Medical News Sentiment IMCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMCR Articles This Week▼84▲IMCR Articles Average Week Get Immunocore News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TGTX News Today VKTX News Today BBIO News Today CRNX News Today KRYS News Today ACLX News Today ADMA News Today RARE News Today APLS News Today BHVN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMCR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunocore Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunocore With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
